Ad is loading...
MNKD
Price
$6.80
Change
-$0.22 (-3.13%)
Updated
Nov 15 closing price
107 days until earnings call
UTHR
Price
$363.25
Change
-$23.02 (-5.96%)
Updated
Nov 15 closing price
94 days until earnings call
Ad is loading...

MNKD vs UTHR

Header iconMNKD vs UTHR Comparison
Open Charts MNKD vs UTHRBanner chart's image
MannKind
Price$6.80
Change-$0.22 (-3.13%)
Volume$5.22M
CapitalizationN/A
United Therapeutics
Price$363.25
Change-$23.02 (-5.96%)
Volume$619.98K
CapitalizationN/A
MNKD vs UTHR Comparison Chart
Loading...
MNKD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
MNKD vs. UTHR commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNKD is a Sell and UTHR is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (MNKD: $6.80 vs. UTHR: $363.25)
Brand notoriety: MNKD and UTHR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNKD: 226% vs. UTHR: 170%
Market capitalization -- MNKD: $1.88B vs. UTHR: $16.22B
MNKD [@Biotechnology] is valued at $1.88B. UTHR’s [@Biotechnology] market capitalization is $16.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNKD’s FA Score shows that 1 FA rating(s) are green whileUTHR’s FA Score has 1 green FA rating(s).

  • MNKD’s FA Score: 1 green, 4 red.
  • UTHR’s FA Score: 1 green, 4 red.
According to our system of comparison, UTHR is a better buy in the long-term than MNKD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNKD’s TA Score shows that 2 TA indicator(s) are bullish while UTHR’s TA Score has 3 bullish TA indicator(s).

  • MNKD’s TA Score: 2 bullish, 6 bearish.
  • UTHR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, UTHR is a better buy in the short-term than MNKD.

Price Growth

MNKD (@Biotechnology) experienced а -7.42% price change this week, while UTHR (@Biotechnology) price change was -11.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

MNKD is expected to report earnings on Mar 04, 2025.

UTHR is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UTHR($16.2B) has a higher market cap than MNKD($1.88B). MNKD has higher P/E ratio than UTHR: MNKD (85.00) vs UTHR (15.96). MNKD YTD gains are higher at: 86.813 vs. UTHR (65.196). UTHR has higher annual earnings (EBITDA): 1.55B vs. MNKD (53.3M). UTHR has more cash in the bank: 3.33B vs. MNKD (248M). MNKD has less debt than UTHR: MNKD (231M) vs UTHR (400M). UTHR has higher revenues than MNKD: UTHR (2.76B) vs MNKD (248M).
MNKDUTHRMNKD / UTHR
Capitalization1.88B16.2B12%
EBITDA53.3M1.55B3%
Gain YTD86.81365.196133%
P/E Ratio85.0015.96533%
Revenue248M2.76B9%
Total Cash248M3.33B7%
Total Debt231M400M58%
FUNDAMENTALS RATINGS
MNKD vs UTHR: Fundamental Ratings
MNKD
UTHR
OUTLOOK RATING
1..100
8237
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
194
SMR RATING
1..100
10049
PRICE GROWTH RATING
1..100
3842
P/E GROWTH RATING
1..100
8438
SEASONALITY SCORE
1..100
28n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UTHR's Valuation (67) in the Pharmaceuticals Other industry is in the same range as MNKD (76) in the Biotechnology industry. This means that UTHR’s stock grew similarly to MNKD’s over the last 12 months.

UTHR's Profit vs Risk Rating (4) in the Pharmaceuticals Other industry is in the same range as MNKD (19) in the Biotechnology industry. This means that UTHR’s stock grew similarly to MNKD’s over the last 12 months.

UTHR's SMR Rating (49) in the Pharmaceuticals Other industry is somewhat better than the same rating for MNKD (100) in the Biotechnology industry. This means that UTHR’s stock grew somewhat faster than MNKD’s over the last 12 months.

MNKD's Price Growth Rating (38) in the Biotechnology industry is in the same range as UTHR (42) in the Pharmaceuticals Other industry. This means that MNKD’s stock grew similarly to UTHR’s over the last 12 months.

UTHR's P/E Growth Rating (38) in the Pharmaceuticals Other industry is somewhat better than the same rating for MNKD (84) in the Biotechnology industry. This means that UTHR’s stock grew somewhat faster than MNKD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MNKDUTHR
RSI
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
52%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
52%
Momentum
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
61%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
52%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
56%
Advances
ODDS (%)
Bullish Trend 12 days ago
87%
Bullish Trend 10 days ago
73%
Declines
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 3 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
66%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
69%
View a ticker or compare two or three
Ad is loading...
MNKD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBHAX14.39-0.05
-0.35%
Neuberger Berman Equity Income A
CBFEX38.10-0.22
-0.57%
American Funds Global Balanced 529E
VELAX17.79-0.14
-0.78%
VELA Large Cap Plus A
MGOYX14.69-0.22
-1.48%
Victory Munder Mid-Cap Core Growth Y
CHCCX4.17-0.09
-2.11%
AB Discovery Growth C

MNKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with QSI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then QSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
-3.13%
QSI - MNKD
44%
Loosely correlated
-5.77%
NTLA - MNKD
44%
Loosely correlated
-7.61%
VCYT - MNKD
44%
Loosely correlated
-2.97%
BEAM - MNKD
43%
Loosely correlated
-8.59%
PGEN - MNKD
42%
Loosely correlated
-7.11%
More

UTHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with MNKD. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then MNKD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
-5.96%
MNKD - UTHR
37%
Loosely correlated
-3.13%
INCY - UTHR
36%
Loosely correlated
-2.39%
HALO - UTHR
35%
Loosely correlated
-15.40%
LOGC - UTHR
28%
Poorly correlated
+1.67%
VRTX - UTHR
28%
Poorly correlated
-3.77%
More